NeuroScan

Scan Analysis

Select Scan Type: Upload Scan:

Status: Awaiting scan input...

Cognitive Test

🕒 Clock-Drawing Test

Draw a clock showing 10 past 11:

⚡ Reaction Time Test

📍 Orientation Test

What is today's date? Where are you right now? What city are you in?

🧩 3-Word Recall

Enter the words you remember (comma-separated):

🗣️ Verbal Fluency Test (Animals)

Name as many animals as possible in 60 seconds:

Patient Questionnaire

Age: Gender: Education Level: Brain Injury History: Social Isolation (1=active, 5=isolated): Family History of Neurodegenerative Disease? Neurodivergent Conditions: Health Conditions: Genetic Risk Factors:
C9orf72
ApoE ε4
APP
PSEN1
PSEN2
TREM2
CX3CR1
HLA-DRB5
MHC
Lifestyle Overview: Current Symptoms (click to select):

Memory loss Poor judgement Poor understanding Poor concentration Personality changes Depression Agitation Confusion Mood swings Balance issues Poor coordination Tremors Difficulties speaking Difficulties swallowing Insomnia Bladder and bowel dysfunction Fatigue Stiffness and rigidity Muscle atrophy

Prediction & Report

Complete questionnaire to generate report.

Reference Sheets

Sleep Quality

Poor: less than 7 hours, frequent awakenings, sleep latency>30 mins
Moderate: 7–8 hours, occasional interruptions
Good: 7–9 hours, consistent bed/wake schedule, restful night.

Physical Activity

Sedentary:30 mins/wk or less
Moderately Active:60 mins/wk
Highly Active:150+ mins/wk

Diet Quality

Poor:High processed food, low nutrients, frequent alcohol
Moderate:Balanced occasional indulgence
Good:Mediterranean/all-plant/omega-3 rich, limited alcohol.

Social Engagement

Poor:Complete isolation, 1-2 interactions/wk
Moderate:Some social activities, 3-4x interactions/wk
Good:Regular meaningful social engagement, 4x+ interactions/wk.

Genetic Factors & Proteins

Genetic mutations: ApoE ε4, C9orf72, APP, PSEN1, PSEN2, TREM2, CX3CR1, MHC, HLA-DRB5.

Protein pathologies: Tau, β-Amyloid, α-Synuclein, TDP-43, Prions.

Mental health conditions: Cluster-b personality disorders, anxiety disorders, Neurodivergent disorders.

Physical Conditions: high blood pressure, high cholesterol, diabetes, obesity, stroke, and head trauma.

Treatment Library

Medical Treatments

Medications for early onset dementia:
-cholinesterase inhibitors
-donepezil (aricept, adlarity)
-rivastigmine (exelon)
-galantamine (zunveyl)
-leqembi/lecenemab
-donanemab
Amyloid targeting meds:-
-lecanemab (leqembi)
-donanemab (kisunla)
Symptom targeting meds:-
-cholinesterase inhibitors
-benzgalantamine(zunveyl) → mild/moderate alz
-donepezil(aricept) → mild/severe alz
-galantamine(razadyne) → mild/moderate alz
-rivastigmine(exelon) → mild/moderate alz/parkinsons
-glutamate regulators
-memantine(namenda) → mod/severe alz
Note:- they pair donepezil + memantine (namzaric) for mod/severe alz
Non-cognitive symptoms (behavioral/psychological)
-orexin receptor antagonist
-suvorexant(belsomra) → insomnia but its effective w mild/mod alz
-atypical antipsychotics ex. (brexpiprazole- rexulti)
-antidepressants/SSRI’s for mood stabilization

Therapies and Rehabilitation

Cognitive rehabilitation & memory training.
Exercise programs (aerobic + resistance).
Social participation & engaging activities.
Sleep hygiene, stress management.

Other Supportive Measures

Late-stage care: advance planning, communication aids, nutritional/respiratory support, caregiver education.

Disclaimer & Sources

This tool is for informational and educational purposes only. It is not a medical device and does not provide diagnosis, treatment, or medical advice. Results may be inaccurate or incomplete. By using this tool, you agree that we are not liable for any decisions, actions, or outcomes related to its use. If you have concerns about your health, please consult a licensed medical professional.